Genmab — April 2020

[troldmanden]

Og hvad skulle det så være?

[E_L]

i can only read the headline , but maybe it is of use for any of
you
https://dagensmedicin.dk/salget-af-darzalex-boomer/

[fillipa]

Ved nogen hvorfor der ikke kan handles Gen 2N certificat hos Nordea får svar om at den ikke udbydes mere....

[nohope]

EL - you can get 14 days access for free at Dagens Medicin.(Unless you have already done that recently)

[fillipa]

Ok tak og det er ikke der er til udløb har du evt en ISINkode til den .....

[fillipa]

Tænker det stort set er samme certicat

[fillipa]

tusind tak god dag

[E_L]

@nohope thks- but i like the headline so much, don't need to read more

[nohope]

I love your attitude Just the right attitude whenever you are doing in new medicne, if the preliminair news are good - then just stop investigating.

[E_L]

haha, any hint to Remdesivir in there?

[E_L]

https://www.nature.com/articles/s41375-020-0810-4 Nature: Daratumumab induces mechanisms of immune activation through CD38+ NK cell targeting full art https://sci-hub.tw/https://www.nature.com/articles/s41375-020-0810-4

[E_L]

https://sci-hub.tw/https://www.nature.com/articles/s41375-020-0810-4

[E_L]

@peter i am not sure, it is a bit confusing as clinical trials still mentions Ph I , and it was only last September that they added lazertinib to the trial

[Sukkeralf]

in cancer trials you normaly calls it phase 1/2 because you always treat patients right away. Genmab got daratumumab approved in third line Dara/POM/Dex based on phase 1/2 data

[Sukkeralf]

If Janssen say they are going to file it does not matter to me if it is based on phase 1/2 data or phase 2 data

[E_L]

[peter12]

@E.L. Im refeering to a patient story I believe sounds trustworthy

[E_L]

In response to the coronavirus crisis, the company has mandated its employees to work for hospitals, nursing homes and other institutions in the public healthcare if needed, and Genmab will continue to pay their salaries.

[E_L]

Van de Winkel adds: ‘Our scientists will also use their knowledge to help with the response to coronavirus disease, to add our expertise and our insights to create an effective therapeutic candidate much more rapidly https://investinholland.com/success-stories/genmab/?utm_campaign=coschedule&utm_source=twitter&utm_medium=nfiaholland&utm_content=Genmab

[Plimsoller]

Good. We need smart people to help these days.